Argenx
ARGX
#459
Rank
โ‚น5.201 T
Marketcap
โ‚น83,230
Share price
-0.65%
Change (1 day)
74.83%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): โ‚น1,415

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น1,498. In 2024 the company made an earnings per share (EPS) of โ‚น1,319 an increase over its 2023 EPS that were of -โ‚น488.87.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,415
2024โ‚น1,319-369.77%
2023-โ‚น488.87-60.46%
2022-โ‚น1,23663.33%
2021-โ‚น756.99-40.37%
2020-โ‚น1,270183.47%
2019-โ‚น447.86123.09%
2018-โ‚น200.7654.93%
2017-โ‚น129.5714.07%
2016-โ‚น113.5913.05%
2015-โ‚น100.47-36.34%
2014-โ‚น157.83209.04%
2013-โ‚น51.07-33.99%
2012-โ‚น77.37185.59%
2011-โ‚น27.09